NYSE American - Delayed Quote USD

IGC Pharma, Inc. (IGC)

0.4390 -0.0176 (-3.85%)
At close: April 24 at 4:00 PM EDT
0.4400 +0.00 (+0.23%)
Pre-Market: 8:00 AM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Ram Mukunda President, CEO & Director 705k -- 1959
Ms. Claudia Grimaldi VP, Principal Financial Officer, Chief Compliance Officer & Non-Independent Director 245k -- 1971
Mr. Rohit Goel Senior Director of Accounting & Principal Accounting Officer -- -- 1994

IGC Pharma, Inc.

10224 Falls Road
Potomac, MD 20854
United States
301 983 0998 https://igcpharma.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
61

Description

IGC Pharma, Inc., a clinical stage biotechnology company, engages in developing cannabinoid-based formulations for treating diseases and conditions, including Alzheimer's disease, dysmenorrhea, premenstrual syndrome, and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease comprising IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63 that is in pre-clinical development. It also markets Holief, a wellness brand that targets women experiencing premenstrual syndrome and menstrual cramps. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.

Corporate Governance

IGC Pharma, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Jul 10, 2024 - Jul 15, 2024
IGC Pharma, Inc. Earnings Call

Related Tickers

INAB IN8bio, Inc.
1.0600
+1.92%
 
ICU SeaStar Medical Holding Corporation
0.5085
+3.80%
 
PXMD PaxMedica, Inc.
0.6920
-3.35%
 
ALLR Allarity Therapeutics, Inc.
1.3700
-3.52%
 
CERO CERo Therapeutics Holdings, Inc.
1.4559
+7.84%
 
TCBP TC Biopharm (Holdings) Plc
1.4700
-6.96%
 
CDIO Cardio Diagnostics Holdings, Inc.
0.7500
-0.20%
 
TCON TRACON Pharmaceuticals, Inc.
1.8900
+2.16%
 
KTRA Kintara Therapeutics, Inc.
0.1373
+3.47%
 
NKGN NKGen Biotech, Inc.
1.7100
-7.57%